Daniel Fremgen, MS

Director, Analytical Development
Aspen Neuroscience Inc.

Poster(s):

• (F1229) Potency Assay Matrix for Dopaminergic Neuron Precursor Cell Replacement Therapy for Parkinson’s Disease
  Friday, June 13, 2025

  4:00 PM - 5:00 PM HK Time